By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


QR Pharma 

259 Radnor Chester Road
Suite 205
Radnor  Pennsylvania  19087  U.S.A.
Phone: 484-253-2296 Fax: 484-253-2288



Company News
QR Pharma Presents New Data On Posiphen In Down Syndrome At The Alzheimer's Disease International Conference (AAIC 2017 London) 7/12/2017 8:48:18 AM
QR Pharma Presents New Data On Posiphen In Alzheimer's And Parkinson's Disease At The 13th AD/PD International Conference 3/16/2017 10:36:05 AM
QR Pharma Release: Company Announces New Scientific Advisory Board 1/24/2017 11:54:23 AM
QR Pharma Raises $800,000 Of Series A Preferred Stock 10/27/2016 10:40:04 AM
QR Pharma Issues $5.7 Million Of Series A Preferred Stock 5/26/2015 10:55:05 AM
Peter Davies, The 2015 Recipient Of The Potamkin Award, Joins The Scientific Advisory Board Of QR Pharma 4/29/2015 11:10:05 AM
QR Pharma Begins Collaboration On Posiphen And Huntington’s Disease 2/4/2015 10:56:29 AM
QR Pharma Announces The Appointment Of New Chairman And New Board Member 1/6/2015 12:14:53 PM
QR Pharma and University of California, Los Angeles (UCLA) Awarded $3 Million US Army Grant to Test Posiphen in Rat Models of Concussion and Blunt Head Trauma 10/10/2013 9:45:05 AM
QR Pharma Release: Posiphen Restores Brain Function, Cognition and Memory in Transgenic Alzheimer Mice 10/22/2012 9:42:17 AM